Ping An Launches AI-Assisted Clinical Decision Support System For Gastroesophageal Cancers

Ping An Launches AI-Assisted Clinical Decision Support System For Gastroesophageal Cancers

by NeoTech Post

Ping An Insurance announced the launch of the artificial intelligence assisted clinical decision support system, AskBob Cancer for Gastroesophageal Cancers, developed by Ping An, National University Hospital, Singapore, and National University Cancer Institute of Singapore.

By analyzing high-quality literature such as global clinical guidelines, meta analysis, and randomized controlled trials, the clinical decision support system can provide doctors with the best treatment recommendation based on the latest clinical evidence given a tumor patient’s disease stage and condition. It automatically identifies the relevant literatures for the treatment plan as evidence support for doctors’ quick understanding. The system also uses machine learning technology to provide customized recommendations based on the clinical practice preferences of different institutions.

AskBob covers more than 15,000 diseases overall and can diagnose 85 common diseases with 90% accuracy. It has been used by 20,000 medical institutions in about 30 provincial-level administrative regions in China, serving more than 450,000 doctors.

Image by StockSnap from Pixabay